These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6529866)

  • 21. Verapamil-induced ventricular regularity in atrial fibrillation. Effects of exercise, isoproterenol, atropine and conversion to sinus rhythm.
    Khalsa A; Olsson SB
    Acta Med Scand; 1979; 205(6):509-15. PubMed ID: 452946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immediate effects of intravenous verapamil on atrial fibrillation.
    Schamroth L
    Cardiovasc Res; 1971 Oct; 5(4):419-24. PubMed ID: 5160447
    [No Abstract]   [Full Text] [Related]  

  • 23. [Delayed-release verapamil hydrochloride in chronic atrial fibrillation. Reducing the heart rate].
    Gonska BD; Wiedey KD
    Fortschr Med; 1990 Sep; 108(27):521-4. PubMed ID: 2227752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial.
    Simpson CS; Ghali WA; Sanfilippo AJ; Moritz S; Abdollah H
    Am Heart J; 2001 Aug; 142(2):E3. PubMed ID: 11479482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of oral verapamil in controlling ventricular rate in patients with chronic atrial fibrillation receiving digoxin.
    Manoharan S; Kaul UA; Khalilullah M
    J Assoc Physicians India; 1986 Apr; 34(4):257-9. PubMed ID: 3759820
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term oral treatment with high doses of verapamil in lone atrial fibrillation.
    Johansson PA; Olsson SB
    Clin Cardiol; 1984 Mar; 7(3):163-70. PubMed ID: 6705301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenously administered digoxin in patients with acute atrial fibrillation: a population pharmacokinetic/pharmacodynamic analysis based on the Digitalis in Acute Atrial Fibrillation trial.
    Hornestam B; Jerling M; Karlsson MO; Held P;
    Eur J Clin Pharmacol; 2003 Mar; 58(11):747-55. PubMed ID: 12634981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem.
    Lewis RV; Irvine N; McDevitt DG
    Eur Heart J; 1988 Jul; 9(7):777-81. PubMed ID: 3169046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antiarrhythmic effects of verapamil].
    Shapiro M; Malo R; Férez S; Martínez-Ríos MA; Salazar E
    Arch Inst Cardiol Mex; 1976; 46(3):305-16. PubMed ID: 1088854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of verapamil and digoxin in the treatment of atrial fibrillation.
    Lewis R; Lakhani M; Moreland TA; McDevitt DG
    Eur Heart J; 1987 Feb; 8(2):148-53. PubMed ID: 3552680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses.
    McAllister RG; Kirsten EB
    Clin Pharmacol Ther; 1982 Apr; 31(4):418-26. PubMed ID: 7060323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation: minimal sampling interval to estimate average rate.
    Watt JH; Donner AP; McKinney CM; Klein GJ
    J Electrocardiol; 1984 Apr; 17(2):153-6. PubMed ID: 6736838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action.
    Sung RJ; Waxman HL; Elser B; Juma Z
    Clin Invest Med; 1980; 3(1-2):41-7. PubMed ID: 7009003
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: spectral analysis of fibrillation waves in the Holter monitoring.
    Niwano S; Fukaya H; Sasaki T; Hatakeyama Y; Fujiki A; Izumi T
    Europace; 2007 Dec; 9(12):1209-15. PubMed ID: 17897926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
    Trappe HJ; Pfitzner P
    Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind crossover randomized trial of intravenously administered verapamil. Its use for atrial fibrillation and flutter following open heart surgery.
    Hwang MH; Danoviz J; Pacold I; Rad N; Loeb HS; Gunnar RM
    Arch Intern Med; 1984 Mar; 144(3):491-4. PubMed ID: 6703818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial activity in atrial fibrillation after intravenous verapamil.
    Aberg H; Furberg B; Nordgren L
    Ups J Med Sci; 1976; 81(3):145-6. PubMed ID: 1014164
    [No Abstract]   [Full Text] [Related]  

  • 38. [Correction of rate and structure of ventricular rhythm in permanent atrial fibrillation: a novel pathogenetic approach].
    Nedostup AV; Blagova OV; Bogdanova EA; Platonova AA
    Kardiologiia; 2004; 44(1):31-8. PubMed ID: 15029146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modification of hemodynamics in tachycardiac atrial fibrillation by metoprolol and verapamil].
    Maier WD; Neuss H; Bilgin Y; Gigler G; Thormann J; Schlepper M
    Z Kardiol; 1983 Aug; 72(8):465-70. PubMed ID: 6624186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved control of atrial fibrillation with combined pindolol and digoxin therapy.
    James MA; Channer KS; Papouchado M; Rees JR
    Eur Heart J; 1989 Jan; 10(1):83-90. PubMed ID: 2702970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.